Tetrahydroharmine
| Clinical data | |
|---|---|
| Other names | THH; 1,2,3,4-Tetrahydroharmine; Leptaflorine; 7-Methoxy-1,2,3,4-tetrahydroharman; 7-Methoxy-1-methyl-1,2,3,4-tetrahydro-β-carboline; 7-MeO-THH |
| Routes of administration | Oral |
| Drug class | Hallucinogen; Oneirogen; Monoamine oxidase inhibitor; Reversible inhibitor of MAO-A; Serotonin reuptake inhibitor; Serotonin receptor modulator |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Elimination half-life | 4.7–8.8 hours |
| Duration of action | Unknown |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H16N2O |
| Molar mass | 216.284 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Tetrahydroharmine (THH), also known as 7-methoxy-1,2,3,4-tetrahydroharman (7-MeO-THH), is a fluorescent indole alkaloid and β-carboline that occurs in the tropical liana species Banisteriopsis caapi.